Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$1.9B
Avg Funding
$74.5M
Cities
22

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Freehold, United States
$9.8M
raised

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Altrincham, United Kingdom
$200.0M
raised

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$150.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wayne, United States
$200.0M
raised

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$40.0M
raised

Omega Therapeutics offers a proprietary epigenomic programming platform.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$175.0M
raised

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saintes, Belgium
$540K
raised

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$230.0M
raised

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mclean, United States
$1.2M
raised

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Moncton, Canada
$47.6M
raised

OrganiGram is a producer and distributor of medical and recreational cannabis.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Victoria, Canada
$63.2M
raised

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$9.6M
raised

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Morristown, United States
$12.0M
raised

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minnesota City, United States
$10.9M
raised

Calyxt is an agbiotech company that focuses on developing healthier crops.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
London, United Kingdom

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$7.9M
raised

Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Red Bank, United States
$35.0M
raised

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$4.5M
raised

Numinus utilizes psychedelic-assisted psychotherapy methods to bring holistic healthcare to patients.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$1.4M
raised

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Feb 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Palo Alto, United States
$125.0M
raised

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$50.1M
raised

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$40.0M
raised

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$275.0M
raised

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

434 Health Care Post-IPO Equity Startups (September 2026) — Page 12 | VCBacked